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Abstract The structures of 5-aminolaevulinic acid dehydratase
complexed with two irreversible inhibitors (4-oxosebacic acid and
4,7-dioxosebacic acid) have been solved at high resolution. Both
inhibitors bind by forming a Schiff base link with Lys 263 at the
active site. Previous inhibitor binding studies have defined the
interactions made by only one of the two substrate moieties
(P-side substrate) which bind to the enzyme during catalysis. The
structures reported here provide an improved definition of the
interactions made by both of the substrate molecules (A- and
P-side substrates). The most intriguing result is the novel finding
that 4,7-dioxosebacic acid forms a second Schiff base with the
enzyme involving Lys 210. It has been known for many years that
P-side substrate forms a Schiff base (with Lys 263) but until now
there has been no evidence that binding of A-side substrate
involves formation of a Schiff base with the enzyme. A catalytic
mechanism involving substrate linked to the enzyme through
Schiff bases at both the A- and P-sites is proposed.
Keywords: 5-Aminolevulinate dehydratase; 4-Oxosebacic acid;
4,7-Dioxosebacic acid; Mechanism
1. Introduction
The enzyme 5-aminolaevulinate dehydratase (ALAD, also
known as porphobilinogen synthase, EC 4.2.1.24) performs its
reaction at the con£uence of the C-5 and Shemin pathways in
tetrapyrrole biosynthesis [1^5]. The enzyme binds two mole-
cules of 5-aminolaevulinic acid and condenses them to form
the pyrrole porphobilinogen (Fig. 1). Four porphobilinogen
molecules are then joined together and cyclised by subsequent
enzymes in the pathway to form uroporphyrinogen III. The
pathway diverges to produce an array of tetrapyrroles includ-
ing cobalamins, chlorophyll and haem which are fundamental
to many biological processes.
The ALAD enzymes share a high degree of sequence iden-
tity, contain about 350 amino acids per subunit and are usu-
ally octameric [1^5]. There are di¡erences between the ALAD
enzymes isolated from various species in terms of their metal
requirements and susceptibility to oxidation. In humans, he-
reditary de¢ciencies in ALAD give rise to the rare disease
Doss porphyria [6] and the inhibition of the enzyme by lead
ions [7] is one of the main symptoms of acute lead poisoning
[8]. 5-Aminolaevulinic acid structurally resembles the neuro-
transmitter GABA [9] and its buildup may be responsible for
some of the neurological symptoms which accompany the in-
hibition of ALAD in Doss porphyria and lead poisoning [10].
Elevated levels of ALA are also found in the hereditary dis-
ease type I tyrosinaemia [11] which is thought to stem from
the accumulation of succinyl acetone, a breakdown product of
tyrosine and a potent inhibitor of ALAD.
The X-ray structures of ALAD from several sources have
shown that the enzyme has a large homo-octameric structure
with each subunit adopting the (L/K)8 or TIM barrel fold with
a 39 residue N-terminal arm forming inter-subunit contacts
[10,12^15]. Each subunit has an N-terminal tail or arm region
which allows pairs of monomers to associate with their arms
wrapped around each other to form compact dimers. Four
dimers, which also interact principally via their arm regions,
form the octamer and create a large solvent ¢lled cavity in the
centre. The active site of each subunit is located in a pro-
nounced cavity formed by loops at the C-terminal ends of
the L-strands forming the TIM barrel. All eight active sites
are oriented towards the outer surface of the octamer and
appear to be independent. At the base of each active site
are two lysine residues (210 and 263), one of which (Lys
263 in yeast ALAD) is known to form a Schi¡ base link to
the substrate. X-Ray structure analysis of inhibitor complexes
revealed that a large £ap covering the active site (residues
215^235) undergoes a substantial increase in order upon for-
mation of the Schi¡ base with the enzyme. In all ALADs,
except for those from plants and some bacteria, there is a
well de¢ned metal binding site at the catalytic centre formed
by three cysteine residues (133, 135 and 143 in yeast ALAD)
and a solvent molecule. Some ALADs also possess a regula-
tory metal binding site which is located between each TIM
barrel domain and the N-terminal arm of a neighbouring sub-
unit in the octamer [13].
In the reaction catalysed by ALAD, two identical molecules
of 5-aminolaevulinic acid are bonded together to form an
asymmetric pyrrole product porphobilinogen. The substrate
molecules (along with each of their associated binding sites)
are named according to which side of the product porphobili-
nogen they will go on to form, namely the acetate (A) or
propionate (P) sides as shown in Fig. 1. The main features
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of the received mechanism are Schi¡ base formation between
one of the substrate molecules and an invariant lysine residue,
the formation of an inter-substrate Schi¡ base and an aldol
condensation. Single turnover experiments have shown that it
is the substrate molecule which goes on to constitute the pro-
pionate side of the product which binds ¢rst and it has been
established that this substrate forms a Schi¡ base with the
enzyme [16^19]. Whether it is C^N or C^C bond formation
between the two substrates which ¢nally closes the pyrrole
ring is still unclear. Whatever the mechanism, at some point
during the reaction a long chain dicarboxylate is created as an
intermediate. If C^C bond formation is ¢rst, the intermediate
will take the form of a seven carbon chain diacid whilst if
C^N bond formation occurs ¢rst, a 10 atom chain diacid
will be formed [20^22]. As has been noted previously, dicar-
boxylic acids may be able to cross-link the carboxylic acid
binding groups associated with the A and P substrate binding
sites [23,24]. Because of this potential we have crystallised the
ALAD from Saccharomyces cerevisiae in complex with the
10 carbon chain diacid irreversible inhibitors 4-oxosebacic
acid and 4,7-dioxosebacic acid (formulae are shown in Fig.
2). These complexes have been subjected to X-ray structural
analysis, the results of which are presented here.
This study shows that the diketo inhibitor binds by forming
Schi¡ bases at the catalytic centre with both of the invariant
lysine residues (263 and 210). Other studies have only pro-
vided evidence that Lys 263 forms a Schi¡ base with the
P-site substrate [12^15]. The ¢nding that the other invariant
lysine at the active site is also capable of making such an
interaction is in accord with a recent proposal for the catalytic
mechanism which speculated that both the A- and P-side sub-
strates bind by making Schi¡ bases with the enzyme [25]. Both
inhibitors de¢ne interactions at the enzyme’s A-site more
clearly than previous studies on binding of inhibitors to yeast
ALAD.
2. Materials and methods
2.1. Data collection and data processing
Co-crystals of yeast ALAD with the inhibitors were obtained using
the hanging-drop method with the same conditions as those used for
the native enzyme [26] except for the addition of the inhibitor to give
a ¢nal concentration of 5 mM in each drop. Crystals of the complexes
appeared within 3^4 weeks and were £ash-cooled in liquid ethane
using V30% glycerol v/v as a cryoprotectant for cryostorage under
liquid nitrogen.
Initial datasets were collected at the EMBL X11 beamline at DESY
(Hamburg) to 2.1 Aî resolution and these were used for the initial
structure determination of the bound inhibitors. Datasets to slightly
higher resolution (around 1.8 Aî ) were then collected at the ID14-2
and ID14-4 beamlines at ESRF (Grenoble) and these were used in the
re¢nement. The data were processed using the program MOSFLM
[27] and were merged with SCALA of the CCP4 suite [28]. The
data collection and processing statistics are shown in Table 1. The
complexes were isomorphous with the native enzyme crystals allowing
the ligand molecules to be located by calculation of di¡erence Fourier
maps using the phases from the native yeast ALAD structure [10].
The structures were re¢ned using SHELX-97-2 [29] initially by rigid
body re¢nement to compensate for small changes in unit cell param-
eters. This was followed by stereochemically restrained least-squares
re¢nement of atomic coordinates and isotropic temperature factors.
The re¢nement was done by gradually increasing the resolution to
achieve a greater radius of convergence. Graphical rebuilding was
done using TURBO-FRODO (Bio-Graphics, Marseille) running on
Silicon-Graphics computers. Various modi¢cations to the restraint
dictionaries were made to incorporate the ligand molecules and to
ensure planarity of the Schi¡ bases formed with the enzyme. The
coordinates of these complexes have been deposited with the Protein
Data Bank (PDB) and the accession codes are shown in Table 1 (to be
done on acceptance of the manuscript).
3. Results
Clear electron density for the bound ligands was found at
the active site in the initial di¡erence Fourier maps con¢rming
that binding to the enzyme had occurred. The structures were
re¢ned to high resolution and the crystallographic R-factors
and free R-factors are given in Table 1 along with other
Fig. 1. The reaction catalysed by 5-aminolaevulinic acid dehydratase
(ALAD). Two molecules of 5-aminolaevulinic acid are condensed to
form the pyrrole porphobilinogen.
Table 1






a, b (Aî ) 103.5 104.3
c (Aî ) 168.2 167.2
Number of crystals 1 1
Statistics for entire dataset
Resolution range (Aî ) 30.4^1.8 36.3^1.75
R-Merge (%) 5.9 11.4
Completeness (%) 94.6 95.5
Multiplicity 5.6 6.2
Mean I/c(I) 4.9 4.6
Statistics for outer shell
Resolution range (Aî ) 1.9^1.8 1.84^1.75
R-Merge (%) 42.5 36.4
Completeness (%) 87.7 98.5
Multiplicity 3.7 3.6
Mean I/c(I) 1.5 1.6
Re¢nement
R-Factor (%) 26.5 23.9
R-Free (%) (5% test set) 32.9 30.6
Totoal number of re£ections 39 906 44 374
RMSD bond lengths (Aî ) 0.006 0.008
RMSD 1^3 distances (Aî ) 0.020 0.023
RMSD bumps (Aî ) 0.006 0.011
RMSD chiral volumes (Aî 3) 0.035 0.044
RMSD planes (Aî 3) 0.029 0.037
In both cases the space group was I422.
Fig. 2. The formulae of the two diacid ALAD inhibitors: 4-oxose-
bacic acid and 4,7-dioxosebacic acid.
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re¢nement statistics. The re¢ned structure of the 4,7-dioxose-
bacic acid complex has 91% of residues within the ‘most fav-
oured’ regions of the Ramachandran plot by the criteria used
in PROCHECK [30]. The 4-oxosebacic acid structure shows a
somewhat higher degree of disorder especially in loops close
to the active site. Accordingly, this structure has slightly poor-
er stereochemistry with 86% of residues within the ‘most fav-
oured’ regions. For the better de¢ned 4,7-dioxosebacic acid
complex, 100% of the residues are within the so-called ‘addi-
tional allowed’ regions which compares with a value of 95%
for the other complex.
The pre¢ned electron density maps for each ligand are
shown in Fig. 3. It appears that the 4-oxosebacic acid mole-
cule is somewhat disordered and the part which binds in the
Fig. 3. The re¢ned electron density maps (shown in purple) for the inhibitors 4,7-dioxosebacic acid at 1.75 Aî resolution (top) and 4-oxosebacic
acid at 1.8 Aî resolution (bottom). The maps are contoured at 1.5 rms (top) and 1.2 rms (bottom).
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P-site has been modelled in two conformations. The same
e¡ect has been found with several other inhibitors which oc-
cupy the P-site [12,31]. In contrast, all of the 4,7-dioxosebacic
acid molecule is de¢ned well by the electron density map. The
absence of disorder in this inhibitor complex may correlate
with the ligand’s more tightly bound state held by two Schi¡
bases with the enzyme.
Studies with substrate 5-aminolaevulinic acid, and the in-
hibitors laevulinic acid, succinyl acetone and 4-keto-5-amino-
hexanoic acid have helped to de¢ne the residues forming the
P-site [12^15, 31]. Both ligands in the present study form a
Schi¡ base with Lys 263 and bind with their P-site carboxyl
groups making hydrogen bonds with Ser 290 and Tyr 329.
These interactions are characteristic of all other P-site ligands
which have been studied previously. These molecules ¢t in a
hydrophobic pocket beneath the active site £ap (215^235)
which becomes substantially more ordered when the inhibitors
bind. This ordering appears to be due to tight hydrophobic
interactions between the P-site ligands and residue Phe 219 in
the £ap. Kinetic studies have suggested that the Km of the
P-site is lower than that of the A-site (4.6 WM as against
66 WM for the Escherichia coli enzyme) [21,22]. This correlates
with the ¢nding that all substrate analogues studied up till
now bind predominantly in the P-site and the adjacent
A-site appears to be occupied only by water molecules, and
a number of the side chains forming this site are disordered.
In consequence the residues which bind the A-side substrate
have been more elusive to de¢ne.
The two inhibitors used in the present study provide good
de¢nition of the A-site residues. The most striking ¢nding is
that the 4,7-dioxosebacic acid makes a second Schi¡ base
through its C-7 keto function with Lys 210. This was clearly
shown by the initial di¡erence electron density and has been
con¢rmed by subsequent re¢nement at 1.8 Aî resolution. The
A-site carboxyl group occupies a similar position in both li-
gands, hydrogen bonding with the amino group of Gln 236.
However, in the more ordered 4,7-dioxosebacic acid complex
it is notable that hydrogen bonds are formed between the
A-site carboxyl group and the guanidinium groups of Arg
220 and Arg 232. Hence these residues are very likely to
form a salt bridge with the carboxylate of A-side substrate.
These arginines (along with Gln 236) are strongly conserved
residues. In the less well de¢ned 4-oxosebacic acid complex,
the interactions with these arginine residues are more distant.
Lys 210 is notably less well ordered in the 4-oxosebacic acid
complex than it appears to be in the Schi¡ base link of the
4,7-dioxosebacic acid complex.
4. Discussion
Most mechanistic proposals for ALAD involve the forma-
tion of a Schi¡ base between the P-side substrate moiety and
an active site lysine (Lys 263 in yeast ALAD). This stems
from labelling studies which indicated that only the P-side
substrate moiety becomes covalently trapped upon reduction
with NaBH4 [19]. It is likely that upon binding of the A-side
substrate the ensuing reaction with P-side substrate is su⁄-
ciently fast to preclude trapping of a Schi¡ base at the A-site
under the conditions used in these earlier studies. The present
¢nding that the dioxo inhibitor forms Schi¡ bases with both
of the invariant active site lysine residues (263 and 210 in
yeast ALAD) suggests that both A- and P-side substrate
may form Schi¡ bases upon productive binding to the en-
zyme.
Fig. 4 shows a proposal for the catalytic mechanism involv-
ing both ALA moieties held by Schi¡ bases with active site
lysine residues. In this mechanism a basic group (shown as (1)
in Fig. 4) is required to abstract a proton from C-3 of A-side
ALA leading to an enamine intermediate. This nucleophili-
cally attacks P-site ALA yielding the C^C bond linking the
two substrates in the ¢nal pyrrole product. We have specu-
lated that base (1) is a zinc-bound hydroxide [13]. This base
could also catalyse a second deprotonation of the A-side C-3,
leading to the formation of an inter-substrate C^C double
bond. This could be followed by nucleophilic attack of the
P-side N-5 on the A-side C-4, leading ultimately to the inter-
substrate C^N bond as well as the cleavage of the Schi¡ base
link between the A-side C-4 and Lys 210.
The proximity of the amino groups of the two active site
lysine residues suggests that each could ful¢l a role as a base
to deprotonate the other at di¡erent stages in the reaction.
Thus we speculate that base (2) which protonates the Schi¡
base nitrogen of Lys 263 may actually be the spatially adja-
cent Schi¡ base involving Lys 210. The latter Schi¡ base could
easily be re-protonated since it is close to a number of polar
side chains in the vicinity of the active site zinc ion. A basic
group (3) is also required for deprotonation of the second
active site lysine (Lys 210) and we speculate that this base
may be Lys 263. In the reaction a base (4) assists the depro-
tonation of the N-5 of P-side ALA. We have speculated that
two proximal active site residues, namely Asp 131 and Ser
Fig. 4. A possible mechanism for ALAD in which both A- and
P-side substrates form Schi¡ bases with the enzyme.
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179, may be involved in this process. The ¢nal deprotonation
shown in Fig. 4 involves the C-5 of P-side ALA. This step,
which has been shown to be stereospeci¢c for the pro-R hy-
drogen [32], could also be catalysed by Lys 263 in view of its
proximity. In the X-ray structure the pro-R hydrogen on C-5
is pointing in the direction of a polar pocket formed by the
side chains of Asp 131, Ser 179, Tyr 207, Tyr 287 and Lys
263. Of these residues the lysine is well placed to catalyse a
deprotonation. In contrast, the pro-S hydrogen points to-
wards an aromatic pocket formed by Phe 46, Phe 89 and
Phe 219. Thus the high resolution X-ray structure of the
4,7-dioxosebacic acid complex is also consistent with the ex-
perimentally observed stereochemistry of the enzyme cata-
lysed reaction.
Early experiments on ALAD suggested a mechanism in
which the substrate at the A-site was initially linked to the
enzyme through a Schi¡ base to facilitate deprotonation at
the C-3 position [33]. Subsequently, single turnover experi-
ments demonstrated that it is not the A-site substrate but
the P-side substrate that binds initially to the enzyme through
a Schi¡ base [16^19]. A major step in the understanding of the
mechanism stemmed from the X-ray structure analysis of
yeast ALAD [10] which revealed two adjacent lysines in the
active site (Lys 263 and Lys 210). This re-opened the possi-
bility that two Schi¡ bases may be involved in the mechanism,
one binding each substrate. This possibility has been further
substantiated by the ¢nding that the inhibitor 4,7-dioxoseba-
cic acid binds by forming Schi¡ bases with both of the active
site lysines.
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